Page 87 - Eshre 2018

References
• Martinez, F. (2017). "Update on fertility preservation from the Barcelona International Society for Fertility Preservation‐ESHRE‐ASRM 2015 expert meeting: indications, results and future perspectives." Hum Reprod 32(9): 1802‐1811.
• Martinez, F. (2017). "Update on fertility preservation from the Barcelona International Society for Fertility Preservation‐ESHRE‐ASRM 2015 expert meeting: indications, results and future perspectives." Fertil Steril 108(3): 407‐415 e411.
• Garcia‐Velasco, J. A., J. Domingo, et al. (2013). "Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications." Fertility and sterility 99(7): 1994‐1999.
• Doyle, J. O., K. S. Richter, et al. (2016). "Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval." Fertil Steril 105(2): 459‐466 e452.
• Cobo, A., J. A. Garcia‐Velasco, et al. (2016). "Oocyte vitrification as an efficient option for elective fertility preservation." Fertil Steril 105(3): 755‐764 e758.
• Cobo, A. and J. A. Garcia‐Velasco (2016). "Why all women should freeze their eggs." Curr Opin Obstet Gynecol 28(3): 206‐210.
• Domingo, J. and J. A. Garcia‐Velasco (2016). "Oocyte cryopreservation for fertility preservation in women with cancer." Curr Opin Endocrinol Diabetes Obes 23(6): 465‐469.
• Stoop, D., J. Nekkebroeck, et al. (2011). "A survey on the intentions and attitudes towards oocyte cryopreservation for non‐medical reasons among women of reproductive age." Human reproduction 26(3): 655‐661.
Page 81 of 135
PRECONGRESS COURSE 16 I BARCELONA, SPAIN – 1 JULY 2018 87